These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6477609)

  • 1. Isolation of acetylcholine receptor-like protein from fetal calf thymus.
    Kawanami S; Yuki M; Oda K; Goto I; Kuroiwa Y
    Biochem Int; 1984 Mar; 8(3):377-83. PubMed ID: 6477609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of acetylcholine receptor-like protein from fetal calf thymus.
    Kawanami S; Kakuno T; Horio T
    Jpn J Psychiatry Neurol; 1987 Mar; 41(1):97-104. PubMed ID: 3626201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor in rabbit thymus: antigenic similarity between acetylcholine receptors of muscle and thymus.
    Ueno S; Wada K; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Dec; 42(3):463-9. PubMed ID: 7214741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of nicotinic acetylcholine receptor-like protein from fetal calf thymus.
    Kawanami S; Conti-Tronconi B; Racs J; Raftery MA
    J Neurol Sci; 1988 Nov; 87(2-3):195-209. PubMed ID: 3210032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T; Mittag TW
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B; Morel E; Bach JF
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular aspects of experimental autoimmune myasthenia gravis.
    Fuchs S; Bartfeld D; Mochly-Rosen D; Schmidt-Hopfeld I; Tarrab-Hazdai R
    Prog Clin Biol Res; 1981; 63():405-17. PubMed ID: 7031685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.
    Navaneetham D; Penn A; Howard J; Conti-Fine BM
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):433-42. PubMed ID: 9193799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B; Bach JF; Morel E
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune myasthenia gravis induced by thymic acetylcholine receptor-like protein.
    Kawanami S; Mori S
    Fukuoka Igaku Zasshi; 1994 Apr; 85(4):120-7. PubMed ID: 8200609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies.
    Wu JT; Astill M; Lloyd C; Salmon VC
    J Clin Lab Anal; 1993; 7(1):11-8. PubMed ID: 8426270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there acetylcholine receptor in human thymus?
    Nicholson GA; Appel SH
    J Neurol Sci; 1977 Oct; 34(1):101-8. PubMed ID: 915531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.